The phenotypical consequences of a combined deficiency of the Fas-Fas Ligand (FasL) and one or both Tumor Necrosis Factor (TNF) signaling pathways were investigated. Mice, which expressed a non-functional FasL suffered from a pathological accumulation of both B and T cells leading to splenomegaly and lymphadenopathy and, depending on the genetic background, pathogenic self-reactive antibodies (generalized lymphoproliferative disorder (gld)-phenotype). If mice additionally lacked TNF, they displayed a significantly ameliorated gld-phenotype while TNF Receptor-1-deficient gld mice (B6.gld.TNFR1 −/− ) displayed a more severe phenotype. To complement this combination, we also generated TNF Receptor-2-deficient gld mice (B6.gld.TNFR2 −/− ). Both double knockouts followed in their splenic structure the respective TNFR contribution to the phenotype. TNFR1 −/− mice showed an absence of B cell follicles in the spleen while TNFR2 −/− mice were comparable
Introduction
Apoptosis is fundamental for the maintenance of both central and peripheral tolerance and the contraction of effector responses in the periphery [1] . Consequently, inhibition of apoptosis leads to lymphoaccumulation and a predisposition to autoimmune disease [2] . Apoptosis facilitates cellular homeostasis in the immune system via the extrinsic pathway [1, 3] , which is triggered by cytokines of the TNF family of ligands [4, 5] . More specifically, the pro-apoptotic cytokine FasL is expressed on a variety of immune cells such as CD8
+ T cells and is involved in the induction of apoptosis via its cognate receptor Fas (FasR) [1] . Two different spontaneous recessive murine mutations have been described that caused the adjournment of immune homeostasis and resulted in massive lymphoaccumulation accompanied by symptoms of an autoimmune disorder comparable to Systemic Lupus Erythematosus (SLE) [6, 7] . Consequently, these mutation-carrying strains have been named lymphoproliferation (lpr) and generalized lymphoproliferative disorder (gld) [7] . As underlying cause of the disorders a complete loss of Fas as well as a loss-of-function mutation of FasL have been identified [5] . Another member of the TNF family, the name giving cytokine TNF, can also trigger apoptosis via the TNFR1 [8] . The involvement of TNFR-1 in the lpr phenotype has been analyzed and an additive pathological activity of Fas and TNFR1 has been demonstrated [9] while a combination of gld and TNF resulted in an attenuated form of lymphadenopathy [10] . To further dissect the signaling pathways involved in the autoimmune pathogenesis of the gld mouse strain gld.TNFR1 −/− and gld.TNFR2 −/− knockout mouse strains were generated and their phenotype was analyzed to compare the phenotypic outcomes from the loss of these receptors.
Results and Discussion

Comparison of the Overall Phenotype of B6.gld.TNFR1 −/− and B6.gld.TNFR2 −/− Mice
We analyzed the phenotypical consequences of the deletions of tnfr1 and tnfr2 in combination with the loss-of-function of fasL and tested the B6.gld.TNFR1 −/− and B6.gld.TNFR2 −/− mouse strains [9, 10] for the influence of these combined mutations on hallmarks of the gld phenotype: The long term survival of the mice and the extent of the splenomegaly. Furthermore, we determined the splenic CCL21 expression because specifically the absence of TNF prevents the expression of this chemokine in B6.gld.TNF −/− mice [11] .
Interestingly, the length of survival of the two genotypes was very similar ( Figure 1A ) and a comparison to previously published data showed that it was not significantly different from the B6.gld strain but shorter than B6. . The titre of CCL21 in spleen tissue was determined by ELISA and was found to be 9.5 (n = 19) and 7 ng/mL (n = 15), respectively. The data for B6.WT, B6.gld and B6.TNFR1 (striped bars) were published previously and were added to this figure as comparison [12] , ***: p ≤ 0.01. Figure 1B ) and B6.gld mice [12] which were bred in our animal facility to previously published data of MRL.lpr.TNFR1 −/− mice [9] can be explained with the increased susceptibility of the MRL strain to the development of the autoimmune phenotype in general, and of splenomegaly and lymphadenopathy, in particular [7] . A phenotypic comparison of the TNFR1 −/− and TNFR2 −/− mice was not carried out. A gross analysis of the cellularity of the spleen of both genotypes has been published previously [13] and could not find a difference to the WT strain [14] .
Previously it has been shown that B6.gld mice overexpress CCL21 and that the absence of TNF specifically prevents this overexpression reducing autoimmune pathology [11] . It was hypothesized that this TNF-dependent CCL21 expression was one of the underlying causes of the accumulation of T cells and B cells in the peripheral lymphoid organs. Since the B6.gld.TNFR1
−/− and B6.gld.TNFR2
−/− mouse strains displayed a significant difference in the size of their spleen we tested the expression of CCL21 in these mouse strains using a CCL21-specific capture ELISA as compared to B6.WT, B6.gld and B6.TNFR1 −/− genotypes which had been published previously [11, 12] . It showed that the expression level of CCL21 in B6.gld.TNFR1 −/− and B6.gld.TNFR2 −/− mouse spleens was not significantly different from each other or from B6.WT spleens but substantially lower as in B6.gld mice ( Figure 1C ). The cytokine TNF and its pro-inflammatory receptor TNFR1 are central for a protective innate immune response in particular to intracellular pathogens such as parasites [15] or bacteria [16] while the functions of the second TNF signaling pathway are still not entirely resolved and are probably involved in immune homeostasis [17] . However, the pro-inflammatory signaling pathway is also associated with chronic inflammation, which is observed in autoimmune diseases such as inflammatory bowel disease (IBD) or rheumatoid arthritis or in a mouse model of systemic lupus erythematosus, gld [16] . The combination of different gene-deficient strains allowed us to investigate how either of the two TNFRpathways or a combination of both contributed to the severe autoimmune disorder gld caused by the absence of a functional FasR-FasL signaling transduction. First, a TNFR1 deficiency on a gld.MRL background leads to a stronger and more accelerated phenotype with a more pronounced splenomegaly and increased titres of autoantibodies [9] . Our results confirm this outcome to some extent but put some emphasis back on the role of the MLR background, which has been described as autoimmune-prone [18, 19] . In this comparative study of B6.gld.TNFR1
−/− mice we observe a longer mean survival time than B6.gld mice and significant splenomegaly and lymph node hypertrophy contrasted with a normal CCL21 expression [10, 11] . This could be explained because the absence of TNFR1 can be responsible for the increased activation of TNFR2 signaling pathways [20] and it could lead to an increased proliferation of T cells [21] . Concurrently, the higher level of NF-kB activation could also antagonize the TNF-induced TNFR2-mediated apoptosis and thus cause lymphoaccumulation [22] . Second, a previously published investigation of the gld/TNF −/− phenotype on a B6 background showed a strong attenuation of the gld symptoms and an absence of splenomegaly [10] . This phenotype could have been caused by the absent proliferative signal through the TNF-TNFR2 signaling pathway and the loss of the anti-apoptotic influence of TNF on T cells [10] . Consequently, we had hypothesized that TNFR2 contributed significantly to the observed autoimmune symptoms and we concluded that a combination of a TNFR2-deficient mouse strain with gld would abrogate most of the phenotype and would be more benign in its phenotype. This was only the case with regard to splenomegaly but not the survival time of B6.gld.TNFR2 −/− mice.
Transfer of CD4 − /CD8 − DN T Cells into TNFR Double Knockouts Follows the Respective TNFR Phenotype and Results in Migration to the Bridging Channels or Ends in the B Cell Area
The separation and shape of T and B cell areas in the spleen are changed by TNF [23] or TNFR1 gene-deficiencies [24] and well-defined B cell follicles are replaced by rim-like B cell structures. ( Figure  2C ; [23, 25] ). In B6.gld and B6.gld.TNF −/− mice an additional population of T cells is detectable that is double negative (DN) for CD4 and CD8 [26] . Previous experiments have shown that the DN T cell populations of B6.gld and B6.gld.TNF −/− mice were positive for CXCR5 and migrated in vitro in response to CXCL13 but did not express CCR7 [11, 27] . After adoptive transfer into a wildtype mouse this population stopped at the splenic bridging channel and proceeded only very slowly into the follicle despite the expression of CXCR5 [27] . This DN T cell population was isolated using flow cytometry, labeled with CFSE and used to test the contribution of structures such as follicles and bridging channels to the cell migration in B6.gld. spleens showed a follicular structure comparable to B6.WT spleens. In these genotypes the transferred DN T cells relocated accordingly and paused at the bridging channels ( Figure 2B,E) . In a previous study we had correlated the expression of CCL21 with the gld-phenotype and had been able to demonstrate that the additional absence of TNF, which caused the disruption of both TNFR signaling pathways and a significant reduction of the CCL21 expression, resulted in a more benign pathology [11] . The implied causal connection between chemokine expression and autoimmune pathology has to be reconsidered. In our current study we show a comparable expression of the chemokine CCL21 in both B6.gld.TNFR1 −/− and B6.gld.TNFR2 −/− spleen yet significantly different cellularity of the lymphoid organs, which is contrasted by migration of DN T cells that purely followed the structure of the splenic architecture. To finally address this question about an influence of CCL21 on the gld-pathology we will need to overexpress the chemokine in the absence of TNF. 
Experimental Section
Mouse Strains
The C57Bl/6(B6).gld.TNFR1 −/− and B6.gld.TNFR2 −/− mouse strains were established by backcrossing B6.gld [7] with B6.TNFR1 −/− or B6.TNFR2 −/− deficient mice, respectively [13] followed by inter-crossing of F1 progeny to achieve homozygosis. Mice homozygous for both the gld mutation and TNFR1 or TNFR2 deficiency were selected using screening primers outlined in previous publications [13, 28] . Additional mouse strains used were B6.FasL.TNF −/− [10] and B6.TNF −/− [23] . The genetically unmodified mouse strain C57BL/6 was used as control. All animals were kept under specific pathogen free conditions in IVC units at the animal research facilities of the Comparative Genomics Centre, James Cook University, Townsville, Australia and the Menzies Research Institute Tasmania, Hobart, Australia. Mice used for the phenotypic comparison ( Figure 1 ) were kept Comparative Genomics Centre, James Cook University, Townsville. Mice of both sexes were used.
Ethics Statement
Care of animals was in accord with institution guidelines of James Cook University, Townsville and the University of Tasmania, Hobart.
CCL21 Elisa
The amount of CCL21 in spleen tissue was determined as described [11] using a Capture-ELISA with purified and biotinylated CCL21 specific antibodies for capture and detection, respectively (R&D Systems, Minneapolis, MN, USA), and recombinant murine CCL21 (R&D Systems) as standard. The resulting chemokine concentration was normalized by tissue weight.
Fluorescence Immunohistology
Spleens were harvested, frozen in Optimal Cutting Temperature (OCT) medium and cut in sections (8 µm). Fluorescence immunohistology was performed as described in detail elsewhere [29] . Antibodies used were: Rat anti mouse µ heavy chain (Cy5), rat anti mouse  heavy chain, rat anti-mouse B220 (purified or biotinylated; clone RA3-6B2; BD Biosciences). Biotinylated B220 was revealed using Streptavidin Alexa 594 or 546, respectively. Purified B220 was revealed with goat anti rat Alexa 488 (Invitrogen, Sydney, Australia). The sections were analyzed using an Olympus BX51 microscope (Olympus, Sydney, Australia) with a high-sensitivity gray-scale digital camera (Olympus Optotronics, Olympus) and Magnifier software (Olympus).
Flow Cytometry
The cells were stained for CD4 (RM4-5, PerCP-Cy5.5) and CD3 (145-2C11, APC-Cy7). Intracellular cytokine flow cytometry was performed as described in detail elsewhere [10] using Cytofix-Cytoperm (BD Biosciences, North Ryde, NSW, Australia) following the manufacturer's instructions and rat anti mouse IFN- (XMG1.2, Alexa Fluor-488). Data were collected using a FACS-Calibur flow cytometer and analyzed with Cell-Quest software (BD Biosciences).
Adoptive Cell Transfer
Lymphocytes were harvested from spleens and lymph nodes of B6.gld mice and CD4 − CD8 − TCR + T cells were isolated using a BD Aria cell sorter (BD Biosciences). The T cells were labelled with carboxyfluorescein diacetate succinimidyl ester (CFSE; Molecular Probes, Invitrogen) as described [30] The spleens of the recipients were harvested 16-24 h after transfer and analysed using immunofluorescence after a co-staining with anti µ and  heavy chain antibodies.
Conclusions
Our investigation of B6.gld.TNFR1 −/− and B6.gld.TNFR2 −/− mice has demonstrated that the clinical outcome in both genotypes followed the respective phenotype, which had been caused by either a deficient TNF-TNFR1 or TNF-TNFR2 signaling pathway. Both genotypes expressed CCL21 at WT level, but while B6.gld.TNFR1 −/− mice showed a modified spleen structure comparable to the TNF-knockout the B6.gld.TNFR2 −/− strain resembled a WT spleen. The data presented formally prove that the presence of the TNF-TNFR2 axis alone contributes to an augmentation of the disorder while the sole presence of TNF-TNFR1 abolishes some effects of the consequences of an inactive FasL such as splenomegaly. Interestingly, a complete absence of TNF signaling does attenuate the gld phenotype which points again at an actively detrimental role of an existing TNF-TNFR2 signaling pathway but could also be due to the anti-apoptotic effect TNF has specifically on T cells. Taken together, we demonstrate that an intact TNFR1 pathway (maintained in the B6.gld.TNFR2 −/− strain) plays a significant role in the prevention of splenomegaly, which is typical for the gld phenotype. For the first time we are able to formally proof that in the absence of the TNF-TNFR2 signaling pathway splenomegaly is prevented yet survival is still reduced.
